Transactions
Affichage de - 375 éléments sur 930
-
2e Group
Financial Advisor (Sell side)
-
US$350m
Bespoke Capital Partners
Joint Bookrunner (Initial Public Offering)
-
US$58m
Alphatec Holdings, Inc.
Joint Bookrunner (CMPO)
-
US$409m
Livongo Health, Inc.
Co-Manager (IPO)
-
US$74m
Castle Biosciences, Inc.
Lead Manager (IPO)
-
N/a
Rezolute
Lead Agent (PIPE)
-
C$916m
Grassroots
Financial Advisor on acquisition by Curaleaf
-
A$14m
Impedimed
Joint Lead Manager & Joint Underwriter (Entitlement Offer)
-
US$575m
Subversive Capital Acquisition Corp.
Sole Bookrunner (IPO)
-
US$150m
Atara Biotherapeutics, Inc.
Co-Manager (CMPO)
-
US$86m
Forty Seven, Inc.
Lead Manager (Follow-on)
-
US$125m
Atreca Inc.
Lead Manager (IPO)
-
US$30m
Sesen Bio Inc.
Sole Bookrunner (CMPO)
-
US$163m
Stoke Therapeutics
Lead Manager (IPO)
-
W2O Group
Financial Advisor to W2O Group on its sale to New Mountain Capital